Neurochemical Research

, Volume 36, Issue 4, pp 668–676 | Cite as

Aspartate Release and Signalling in the Hippocampus

  • J. Victor NadlerEmail author


The Ca2+-dependent release of aspartate from hippocampal preparations was first reported 35 years ago, but the functional significance of this process remains uncertain. Aspartate satisfies all the criteria normally required for identification of a CNS transmitter. It is synthesized in nerve terminals, is accumulated and stored in synaptic vesicles, is released by exocytosis upon nerve terminal depolarization, and activates postsynaptic NMDA receptors. Aspartate may be employed as a neuropeptide-like co-transmitter by pathways that release either glutamate or GABA as their principal transmitter. Aspartate mechanisms include vesicular transport by sialin, vesicular content sensitive to glucose concentration, release mainly outside the presynaptic active zones, and selective activation of extrasynaptic NR1-NR2B NMDA receptors. Possible neurobiological functions of aspartate in immature neurons include activation of cAMP-dependent gene transcription and in mature neurons inhibition of CREB function, reduced BDNF expression, and induction of excitotoxic neuronal death. Recent findings suggest new experimental approaches toward resolving the functional significance of aspartate release.


Aspartate Hippocampus Synaptic transmission Sialin KB-R7943 NMDA receptor 



I thank the many collaborators who contributed their efforts toward these studies. Special thanks go to Dianna Johnson, without whose collaboration the study of excitatory hippocampal transmitters might not have got off the ground, and Carl Cotman, who supported and encouraged this line of research. I also wish to acknowledge the generous support of my laboratory’s studies of aspartate transmission by grants NS 16064 and NS 47096 from the National Institutes of Health.


  1. 1.
    Bliss TVP, Lømo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331–356PubMedGoogle Scholar
  2. 2.
    Bliss TVP, Gardner-Medwin AR (1973) Long-lasting potentiation of the dentate area in the unanaesthetized rabbit following stimulation of the perforant path. J Physiol 232:357–374PubMedGoogle Scholar
  3. 3.
    Cotman CW, Nadler JV (1978) Reactive synaptogenesis in the hippocampus. In: Cotman CW (ed) Neuronal plasticity. Raven, New York, pp 227–271Google Scholar
  4. 4.
    Curtis DR, Phillis JW, Watkins JC (1960) The chemical excitation of spinal neurones by certain acidic amino acids. J Physiol 150:656–682PubMedGoogle Scholar
  5. 5.
    Curtis DR, Watkins JC (1960) The excitation and depression of spinal neurones by structurally related amino acids. J Neurochem 6:117–141PubMedCrossRefGoogle Scholar
  6. 6.
    Nadler JV, Vaca KW, White WF et al (1976) Aspartate and glutamate as possible transmitters of excitatory hippocampal afferents. Nature 260:538–540PubMedCrossRefGoogle Scholar
  7. 7.
    Nadler JV, White WF, Vaca KW et al (1977) Characterization of putative amino acid transmitter release from slices of rat dentate gyrus. J Neurochem 29:279–290PubMedCrossRefGoogle Scholar
  8. 8.
    Gundersen V, Ottersen OP, Storm-Mathisen J (1991) Aspartate- and glutamate-like immunoreactivities in rat hippocampal slices: depolarization-induced redistribution and effects of precursors. Eur J Neurosci 3:1281–1299PubMedCrossRefGoogle Scholar
  9. 9.
    Gundersen V, Chaudhry FA, Bjaalie JG et al (1998) Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. J Neurosci 18:6059–6070PubMedGoogle Scholar
  10. 10.
    Gundersen V, Holten AT, Storm-Mathisen J (2004) GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission. Mol Cell Neurosci 26:156–165PubMedCrossRefGoogle Scholar
  11. 11.
    Larsson M, Persson S, Ottersen OP et al (2001) Quantitative analysis of immunogold labeling indicates low levels and non-vesicular localization of L-aspartate in rat primary afferent terminals. J Comp Neurol 430:147–159PubMedCrossRefGoogle Scholar
  12. 12.
    Persson S, Broman J (2004) Glutamate, but not aspartate, is enriched in trigeminothalamic tract terminals and associated with their synaptic vesicles in the rat nucleus submedius. Exp Brain Res 157:152–161PubMedCrossRefGoogle Scholar
  13. 13.
    Gundersen V, Fonnum F, Ottersen OP et al (2001) Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study. J Cereb Blood Flow Metab 21:41–51PubMedCrossRefGoogle Scholar
  14. 14.
    Burke SP, Nadler JV (1988) Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J Neurochem 51:1541–1551PubMedCrossRefGoogle Scholar
  15. 15.
    Zhou M, Peterson CL, Lu Y-B et al (1995) Release of glutamate and aspartate from CA1 synaptosomes: selective modulation of aspartate release by ionotropic glutamate receptor ligands. J Neurochem 64:1556–1566PubMedCrossRefGoogle Scholar
  16. 16.
    Bradford SE, Nadler JV (2004) Aspartate release from rat hippocampal synaptosomes. Neuroscience 128:751–765PubMedCrossRefGoogle Scholar
  17. 17.
    Nicholls D, Attwell D (1990) The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11:462–468PubMedCrossRefGoogle Scholar
  18. 18.
    Peterson CL, Thompson MA, Martin D et al (1995) Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism. J Neurochem 64:1152–1160PubMedCrossRefGoogle Scholar
  19. 19.
    Herrero MT, Oset-Gasque MJ, Cañadas C et al (1998) Effect of various depolarizing agents on endogenous amino acid transmitter release in rat cortical neurons in culture. Neurochem Int 32:257–264PubMedCrossRefGoogle Scholar
  20. 20.
    Fleck MW, Barrionuevo G, Palmer AM (2001) Synaptosomal and vesicular accumulation of L-glutamate, L-aspartate and D-aspartate. Neurochem Int 39:217–225PubMedCrossRefGoogle Scholar
  21. 21.
    Cavallero A, Marte A, Fedele E (2009) L-Aspartate as an amino acid neurotransmitter: mechanisms of the depolarization-induced release from cerebrocortical synaptosomes. J Neurochem 110:924–934PubMedCrossRefGoogle Scholar
  22. 22.
    Iwamoto T, Watano T, Shigekawa M (1996) A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271:22391–22397PubMedCrossRefGoogle Scholar
  23. 23.
    Holten AT, Morland C, Nordengen K et al (2008) Vesicular release of L- and D-aspartate from hippocampal nerve terminals: immunogold evidence. Open Neurosci J 2:51–58CrossRefGoogle Scholar
  24. 24.
    McMahon HT, Foran P, Dolly JO et al (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. J Biol Chem 267:21338–21343PubMedGoogle Scholar
  25. 25.
    Fleck MW, Barrionuevo G, Palmer AM (2001) Release of D-threo-β-hydroxyaspartate as a false transmitter from excitatory amino acid-releasing nerve terminals. Neurochem Int 39:75–81PubMedCrossRefGoogle Scholar
  26. 26.
    Rossetto O, Morbiato L, Caccin P et al (2006) Presynaptic enzymatic neurotoxins. J Neurochem 97:1534–1545PubMedCrossRefGoogle Scholar
  27. 27.
    Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717–766PubMedGoogle Scholar
  28. 28.
    Simpson LL (2004) Identification of the major steps in botulinum neurotoxin action. Annu Rev Pharmacol Toxicol 44:167–193PubMedCrossRefGoogle Scholar
  29. 29.
    Wang L, Nadler JV (2007) Reduced aspartate release from rat hippocampal synaptosomes loaded with Clostridial toxin light chain by electroporation: evidence for an exocytotic mechanism. Neurosci Lett 412:239–242PubMedCrossRefGoogle Scholar
  30. 30.
    Sobolevsky AI, Khodorov BI (1999) Blockade of NMDA channels in acutely isolated rat hippocampal neurons by the Na+/Ca2+ exchange inhibitor KB-R7943. Neuropharmacology 38:1235–1242PubMedCrossRefGoogle Scholar
  31. 31.
    Arawaka N, Sakaue M, Yokoyama I et al (2000) KB-R7943 inhibits store-operated Ca2+ entry in cultured neurons and astrocytes. Biochem Biophys Res Comm 279:354–357CrossRefGoogle Scholar
  32. 32.
    Pintado AJ, Herrero CJ, Garcia AG et al (2000) The novel Na+/Ca2+ exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors. Brit J Pharmacol 130:1893–1902CrossRefGoogle Scholar
  33. 33.
    Kraft R (2007) The Na+/Ca2+ exchange inhibitor KB-R7943 potently blocks TRPC channels. Biochem Biophys Res Comm 361:230–236PubMedCrossRefGoogle Scholar
  34. 34.
    Liang GH, Kim JA, Seol GH et al (2008) The Na+/Ca2+ exchange inhibitor KB-R7943 activates large-conductance Ca2+-activated K+ channels in endothelial and vascular smooth muscle cells. Eur J Pharmacol 582:35–41PubMedCrossRefGoogle Scholar
  35. 35.
    Chung YH, Ahn HS, Kim D et al (2006) Immunohistochemical study on the distribution of TRPC channels in the rat hippocampus. Brain Res 1085:132–137PubMedCrossRefGoogle Scholar
  36. 36.
    Zhou J, Du W, Zhou K et al (2008) Critical role of TRPC6 channels in the formation of excitatory synapses. Nat Neurosci 11:741–743PubMedCrossRefGoogle Scholar
  37. 37.
    Szerb JC (1988) Changes in the relative amounts of aspartate and glutamate released and retained in hippocampal slices during stimulation. J Neurochem 50:219–224PubMedCrossRefGoogle Scholar
  38. 38.
    McNay EC, Gold PE (1999) Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain and age. J Neurochem 72:785–790PubMedCrossRefGoogle Scholar
  39. 39.
    Burke SP, Nadler JV (1989) Effects of glucose deficiency on glutamate/aspartate release and excitatory synaptic responses in the hippocampal CA1 area in vitro. Brain Res 500:333–342PubMedCrossRefGoogle Scholar
  40. 40.
    Fleck MW, Henze DA, Barrionuevo G et al (1993) Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus. J Neurosci 13:3944–3955PubMedGoogle Scholar
  41. 41.
    Reimer RJ, Edwards RH (2004) Organic anion transport is the primary function of the SLC17/type 1 phosphate transporter family. Pflügers Arch 447:629–635PubMedCrossRefGoogle Scholar
  42. 42.
    Miyaji T, Echigo N, Hiasa M et al (2008) Identification of a vesicular aspartate transporter. Proc Natl Acad Sci USA 105:11720–11724PubMedCrossRefGoogle Scholar
  43. 43.
    Prolo LM, Vogel H, Reimer RJ (2009) The lysosomal sialic acid transporter sialin is required for normal CNS myelination. J Neurosci 29:15355–15365PubMedCrossRefGoogle Scholar
  44. 44.
    Li D, Ropert N, Koulakoff A et al (2008) Lysosomes are the major vesicular compartment undergoing Ca2+-regulated exocytosis from cortical astrocytes. J Neurosci 28:7648–7658PubMedCrossRefGoogle Scholar
  45. 45.
    Aula N, Kopra O, Jalanko A et al (2004) Sialin expression in the CNS implicates extralysosomal function in neurons. Neurobiol Dis 15:251–261PubMedCrossRefGoogle Scholar
  46. 46.
    Yatsushiro S, Yamada H, Kozaki S et al (1997) L-Aspartate but not the D form is secreted through microvesicle-mediated exocytosis and is sequestered through Na+-dependent transporter in rat pinealocytes. J Neurochem 69:340–347PubMedCrossRefGoogle Scholar
  47. 47.
    Yarovaya N, Schot R, Fodero L et al (2005) Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated. Neurobiol Dis 19:351–365PubMedCrossRefGoogle Scholar
  48. 48.
    Aula N, Salomäki P, Timonen R et al (2000) The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation. Am J Hum Genet 67:832–840PubMedCrossRefGoogle Scholar
  49. 49.
    Morin P, Sagné C, Gasnier B (2004) Functional characterization of wild-type and mutant human sialin. EMBO J 23:4560–4570PubMedCrossRefGoogle Scholar
  50. 50.
    Wreden CC, Wlizla M, Reimer RJ (2005) Varied mechanisms underlie the free sialic acid storage disorders. J Biol Chem 280:1408–1416PubMedCrossRefGoogle Scholar
  51. 51.
    Patneau DK, Mayer ML (1990) Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 10:2385–2399PubMedGoogle Scholar
  52. 52.
    Curras MC, Dingledine R (1992) Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Mol Pharmacol 41:520–526PubMedGoogle Scholar
  53. 53.
    Frauli M, Neuville P, Vol C et al (2006) Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors. Neuropharmacology 50:245–253PubMedCrossRefGoogle Scholar
  54. 54.
    Thomas CG, Miller AJ, Westbrook GL (2006) Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J Neurophysiol 95:1727–1734PubMedCrossRefGoogle Scholar
  55. 55.
    Erreger K, Geballe MT, Kristensen A et al (2007) Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72:907–920PubMedCrossRefGoogle Scholar
  56. 56.
    Fonnum F, Paulsen RH, Fosse VM et al (1986) Synthesis and release of amino acid transmitters. In: Schwarcz R, Ben-Ari Y (eds) Excitatory amino acids and epilepsy. Advances in Experimental medicine and biology, 203. Plenum, New York, pp 285–293Google Scholar
  57. 57.
    Szerb JC, O’Regan PA (1987) Reversible shifts in the Ca2+-dependent release of aspartate and glutamate from hippocampal slices with changing glucose concentrations. Synapse 1:265–272PubMedCrossRefGoogle Scholar
  58. 58.
    Zhang X, Nadler JV (2009) Postsynaptic response to stimulation of the Schaffer collaterals with properties similar to those of synaptosomal aspartate release. Brain Res 1295:13–20PubMedCrossRefGoogle Scholar
  59. 59.
    Almeida LEF, Murray PD, Zielke HR et al (2009) Autocrine activation of neuronal NMDA receptors by aspartate mediates dopamine- and cAMP-induced CREB-dependent gene transcription. J Neurosci 29:12702–12710PubMedCrossRefGoogle Scholar
  60. 60.
    Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5:405–414PubMedGoogle Scholar
  61. 61.
    Vanhoutte P, Bading H (2003) Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr Opinion Neurobiol 13:366–371CrossRefGoogle Scholar
  62. 62.
    Wahl A-S, Buchthal B, Rode F et al (2009) Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-D-aspartate receptors. Neuroscience 158:344–352PubMedCrossRefGoogle Scholar
  63. 63.
    Baird DH, Trenkner E, Mason CA (1996) Arrest of afferent axon extension by target neurons in vitro is regulated by the NMDA receptor. J Neurosci 16:2642–2648PubMedGoogle Scholar
  64. 64.
    Rocha M, Sur M (1995) Rapid acquisition of dendritic spines by visual thalamic neurons after blockade of N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 92:8026–8030PubMedCrossRefGoogle Scholar
  65. 65.
    Nacher J, Rosell DR, Alonso-Llosa G et al (2001) NMDA receptor antagonist treatment induces a long-lasting increase in the number of proliferating cells, PSA-NCAM-immunoreactive granule neurons and radial glia in the adult rat dentate gyrus. Eur J Neurosci 13:512–520PubMedCrossRefGoogle Scholar
  66. 66.
    Nadler JV, Evenson DA, Cuthbertson GJ (1981) Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons. Neuroscience 6:2505–2517PubMedCrossRefGoogle Scholar
  67. 67.
    Breder J, Sabelhaus CF, Opitz T, Reymann KG, Schröder UH (2000) Inhibition of different pathways influencing Na+ homeostasis protects organotypic hippocampal slice cultures from hypoxic/hypoglycemic injury. Neuropharmacology 39:1779–1787PubMedCrossRefGoogle Scholar
  68. 68.
    Schröder UH, Breder J, Sabelhaus CF, Reymann KG (1999) The novel Na+/Ca2+ exchange inhibitor KB-R7943 protects CA1 neurons in rat hippocampal slices against hypoxic/hypoglycemic injury. Neuropharmacology 38:319–321PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Pharmacology and Cancer Biology and Department of NeurobiologyDuke University Medical CenterDurhamUSA

Personalised recommendations